Clinical Trial Update: Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating calcitriol plus dexamethasone for hormone-refractory prostate cancer has completed. The study, conducted by the University of Pi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Pittsburgh | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED